What's in Chesapeake Urology Research Associates's pipeline?

Chesapeake Urology Research Associates has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Chesapeake Urology Research Associates's portfolio?

Top competitors by shared drug class: AbbVie (prior sponsor, Abbott), Abbott, Bayer, Changchun GeneScience Pharmaceutical Co., Ltd., Chong Qing Reproducive and Genetic Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/chesapeake-urology-research-associates.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Chesapeake Urology Research Associates — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chesapeake Urology Research Associates pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Eligard (TM)	Eligard (TM)	marketed	GnRH agonist	GnRH receptor	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie (prior sponsor, Abbott) · 1 shared drug class
Abbott · 1 shared drug class
Bayer · 1 shared drug class
Changchun GeneScience Pharmaceutical Co., Ltd. · 1 shared drug class
Chong Qing Reproducive and Genetic Institute · 1 shared drug class
Colorado Center for Reproductive Medicine · 1 shared drug class
Enteris BioPharma Inc. · 1 shared drug class
AbbVie · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Chesapeake Urology Research Associates:

Cite this brief

Drug Landscape (2026). Chesapeake Urology Research Associates — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/chesapeake-urology-research-associates. Accessed 2026-05-17.